NFE2L2 and Anxiety: Current studies indicated that EDA attenuated CSDS-evoked depressive symptoms and CSDS-induced anxiety behaviors, and the underlying mechanisms were associated with the alteration of expression of Sirt1/Nrf2/HO-1/Gpx4 pathway in the Hip.